Slide 1: FY25 Full Year results
FY25 Full Year results August 2025
Slide 2: Pro Medicus – Leaders in Enterprise Imaging and Radiology Information Systems
Pro Medicus (ASX:PME) – Leaders in Enterprise Imaging and Radiology Information Systems (RIS) EU HQ/R&D GROUP HQ Berlin, Germany Melbourne, AUS North American HQ San Diego, CA USA
Slide 3: Pro Medicus (ASX:PME)
Pro Medicus (ASX:PME) VISAGE RIS VISAGE 7 Enterprise Imaging Platform 3
Slide 4: Results FY 2025
Results FY 2025 $213.0M $115.2M $157.7M 74.0% Revenue Profit after tax Underlying EBIT Underlying EBIT up 31.9% up 39.2% up 40.5% margins $210.7M $0.30 Cash & Company is Strong Final dividend FF investments debt free balance sheet up 37.5% up 35.5%
Slide 5: FY 2025 – Results
FY 2025 – Results • Record year • Seven new contracts totaling AUD $520M (at minimums) • Two large contract renewals – worth AUD $130M • Upgrades for additional products – additional AUD $39M • Completed seven cloud-based implementations • Signed research collaboration agreement with UCSF • RSNA 202
Slide 6: Highlights FY 2025
Highlights FY 2025 $5M/7 years New Contract Continues to grow JULY 2024 STRONGLY $330M/10 years CURRENT New Contract PIPELINE NOVEMBER 2024 $30M/7 years New Contract DECEMBER 2024 $33M/9 years New Contract JANUARY 2025 $53M/7 years New Contract FEBRUARY 2025
Slide 7: Highlights FY 2025
Highlights FY 2025 Continues to grow $40M/7 years $20M/5 years STRONGLY New Contract New Contract CURRENT PIPELINE MARCH 2025 APRIL 2025 $24M/5 years $14M/5 years V7 OA and Worklist V7 OA APRIL 2025 JUNE 2025 $98M/8 years $32M/5 years Renewal Contract Renewal Contract OCTOBER 2024 OCTOBER 2024 NOVEM
Slide 8: FY 2025 Revenue Split
FY 2025 Revenue Split Full year revenue split Exam/licence revenue*** Support/baseline revenue*** Professional Services*** Archive data migration $250,000,000 ***Recurring revenue $16,821,000 $200,000,000 $11,757,000 $26,059,000 $7,371,000 $150,000,000 $9,954,000 $22,249,000 $2,059,000 $8,260,000 $2
Slide 9: Operating Leverage
Operating Leverage • Highly scalable offering • No capex (HW) – SW only model • Training & Installation – charged as professional services • Highly contained cost base • Margin continues to grow as footprint increases
Slide 10: Operational (Transaction) Model
Operational (Transaction) Model • Used in vast majority of US contracts • Delivered as SaaS model • Now used in RIS contracts in AUS • Model based on transaction minimums • Forward revenue > A$948M/5 years* • Upside as client examination volumes grow • Annuity style revenue stream – greater predicta
Slide 11: In Review
In Review 2025/2026 Top Hospitals (alphabetical order) Out of the top-rated U.S. hospitals (11 out of 20) use Visage 7 for PACS.
Slide 12: Increasing Footprint in the IDN Space
Increasing Footprint in the IDN Space • IDNs represent the largest segment of the market • IDN clients across broad spread of opportunities from large multi-state to smaller regional • Most recent IDN sales for more than one Visage product – many “full stack”. • All recent IDN opportunities Cloud de
Slide 13: Visage RIS
Visage RIS - Dr R Simpson (rsna) visage2 (2) @ Visage General Hospital (ris.promed.com.au) RECEPTION TECHNOLOGIST DOCTOR TRANSCRIPTIONIST SEARCH OFFICE CLAIMING SETUP Recent Dr R Simpson Appointments Requested Arrival Billing Banking RIS Region Book Tue, 17-Oct-2017 AM PM Patient Procedure Reset Nor
Slide 14: Long term contracts with Lumus and I-MED
• Long term (5 year) contracts with Lumus (Primary Healthcare) and I–MED, the 2 biggest radiology providers in AUS • Upside via client organic and M&A growth • Increased market interest – new opportunities • PME undisputed market leader
Slide 15: SPEED | FUNCTIONALITY | SCALABILITY
SPEED | FUNCTIONALITY | SCALABILITY
Slide 16: Massive Data Explosion
Massive Data Explosion • High density Multi-slice CT - 10,000+ images • HD Breast Tomosynthesis - 6 GB+ • Optoacoustic breast ultrasound - 10+ GB • Total Body PET Scan - 10+ GB • 7T MRI - much larger than 3T
Slide 17: Legacy Technology
Legacy Technology “Compress & Send” PACS MODALITIES RADIOLOGIST/CLINICIAN
Slide 18: Solution
Solution “Streaming Technology” MODALITIES RADIOLOGIST/CLINICIAN
Slide 19: Trinity Health
Trinity Health • One of the top 10 IDNs in North America • $330M (minimum), 10-year deal • Full Stack – Viewer worklist and archive • To be fully cloud deployed • Implementation to commence in October 2025 • Regions phased in over 18-month period • One of the largest deals in radiology IT 19
Slide 20: Private Market
Private Market • Previously “dormant” due to increased M&A activity • Duly Health $30M – 7 Year deal (Dec 2024) • Lucid Health $40M - 7 Year deal (March 2025) • Confirms Visage platform suited to broad range • market segments • Opens more opportunities in the private market space 20
Slide 21: Renewals
Renewals • 2 key renewals in 1st half • Mercy $98M, 8-year renewal • Large RIS customer $32M, 5-year renewal • 100% renewal rate to date • All renewals at higher price point than original contracts • Many for longer terms than original contract 21
Slide 22: Visage 7 OA - Upgrades
Visage 7 OA - Upgrades • 2 key upgrades to V7 Open Archive • NYU - additional $24M, 5-year • Duke - additional $15M, 5-year • V7 Open Archive - catalyst for transition to cloud • Seamless upgrade path for Viewer only, on-premise clients 22
Slide 23: Solution
VISAGE 7° STREAMING PLATFORM Solution O} one vieweR™ FOR ALL ALL PHYSICIANS & CLINICIANS a Visage i sscenltec es me ALL MODALITIES. ALL LOCATIONS. OQ} Visage’ 7 | Open Archive
Slide 24: Fast Track Implementation
Fast Track Implementation • All implementations on or ahead of schedule • Fast track methodology continues to deliver • Large scale projects completed in under 1/4 to 1/5 the time of industry norm • Delivers huge savings for client • Frees PME staff for other jobs • Reduces barrier to change • Highl
Slide 25: Visage – Proven ROI
Visage – Proven ROI Significant IT & Unparalleled increase in Greater Clinical Accuracy Infrastructure Savings Radiologist Efficiency Improved Physician Delivers Superior Engagement Value Proposition
Slide 26: Visage 7 Brings Relief – Burnout – the new epidemic?
Visage 7 Brings Relief – Burnout – the new epidemic? • Acute worldwide shortage of radiologists • Reduced intake of radiology residents – fears AI would take over • Larger datasets – more images to look at • Work life balance post COVID – work from home mandatory part of the mix • Many groups strugg
Slide 27: Clinical Outcomes – Moving the Needle
Clinical Outcomes – Moving the Needle
Slide 28: Growth Strategy
Growth Strategy New product offerings Transaction Extend to new growth from geographical existing clients markets Leverage R&D capability Expand footprint to introduce next – new clients generation products
Slide 29: North American – TAM
North American – TAM • 670 Million exams performed per annum in the US • Growing by ~ 2% to 3% per year • Visage able to address 100% of TAM from a product perspective • ~ 85% of TAM addressable from commercial perspective – “full stack”, Cloud etc • Current market penetration is 10% and growing • V
Slide 30: North American Pipeline
North American Pipeline Pipeline Robust Opportunities Network Effect Prospects In terms of quality and Increased number of Further increased from recent Progressing through quantity of opportunities inbound RFPs high-profile wins in both Tier various stages of the cycle 1academic and IDN markets
Slide 31: Visage 7 Open Archive
Visage 7 Open Archive • Same highly scalable Visage 7 platform • Interoperable – works in complex environments • Enables choice of modular or single vendor solutions • Visage 7 Open Archive integral part of “Full Stack” solution • Pipeline - most opportunities include Visage 7 Open Archive • Key com
Slide 32: Visage 7 Workflow
Visage 7 Workflow • Adds to Visage 7 Viewer and Open Archive modules • Based on over 30 years experience in Workflow SW • Allows PME to offer “full stack” solution • Integral part of Visage CloudPACS SaaS solution • Ability to interface with broad range of AI algorithms • Sold in majority of new con
Slide 33: Visage 7 CloudPACS
Visage 7 CloudPACS • Visage 7 – fully Cloud native • Same ultrafast performance as on-premise • Full Visage 7 functionality • Security and scale of the cloud • Suitable for all size implementations
Slide 34: Visage 7 CloudPACS
Visage 7 CloudPACS • Pipeline opportunities mandating Cloud deployment. • Cloud vendor agnostic - large scale implementations in all three clouds - AWS, Azure and Google GCP • Significant strategic advantage over competitors
Slide 35: Visage 7 One Viewer - All Modalities
Visage 7 One Viewer - All Modalities • Single viewer for ALL images in the medical record (EMR) • Radiology/Cardiology (DICOM format) • Non-radiology– reflected light – hi-res photos & videos • Same code base as Visage 7 platform • Increases Visage value proposition • Growth opportunities within exi
Slide 36: Visage 7 | Cardiology
Visage 7 | Cardiology • Cloud-based Workflow and Imaging Solutions for Cardiology Imaging • Same code base as Visage 7 platform • Ultrafast, immediate access to massive Cardiology datasets • Native Cardiology Imaging tools • Advanced interoperability, - export measurements to Epic Cupid
Slide 37: Visage 7 | Digital Pathology
Visage 7 | Digital Pathology • Native support within the Visage 7 Enterprise Imaging Platform ( WIP - Q4 2025) • Fully Cloud-based (Visage 7 | CloudPACS) • Spatial computing support via Visage Ease VP for Apple Vision Pro (WIP – Q4 2025) • Validation of IHE Digital Pathology Profile at the 2025 IHE-
Slide 38: Visage 7 | AI
Visage 7 | AI • Breast cancer detection algorithm co- developed with NYU - commercialisation pending FDA clearance • Investment in Elucid for Cardiac CT AI • Investment in 4DX – Lung AI • Research collaboration agreement with UCSF, a top AMC • Growing number of 3rd party AI integrations
Slide 39: AI Research Leadership
AI Research Leadership Malte Westerhoff, PhD Detlev Stalling, PhD MingDe Lin, PhD Global Chief Technology Officer Head of Development Clinical Research Manager, North America
Slide 40: Visage Ease VP for Apple Vision Pro
Visage Ease VP for Apple Vision Pro • Launched 5th February with launch of Apple Vision Pro • Visage’s cinematic rendering engine natively embedded in Visage Ease VP • Supports virtual screens at more than 4K resolution for each eye • Immersive, spatial experiences for diagnostic imaging and multime
Slide 41: Visage Ease VP for Apple Vision Pro
Visage Ease VP for Apple Vision Pro “Underpins our belief that our technology is 18 to 24 months ahead of competitors, if not more.”
Slide 42: Visage Ease VP for Apple Vision Pro Video
Visage Ease VP for Apple Vision Pro Video
Slide 43: RSNA 2024
RSNA 2024 ® Visace IMAGING proémedicus — Visace Tmacinc
Slide 44: RSNA 2024
RSNA 2024 proémedicus — Visace Tmacinc
Slide 45: In Summary
In Summary • Most successful year in company’s history by any measure • Expanded product portfolio – “full stack” solution • Proven implementation & support capability • Cloud – huge strategic advantage over competitors • Unparalleled value proposition both clinical and financial RoI • North America
Slide 46: Thank you.
, % prosmedicus — Visace IMAGING’ Thank you.